放疗调控circRNA ACAP2/miR-1-3p/CENPF轴对结直肠癌细胞铁死亡的影响OA
The effect of radiotherapy regulates circRNA ACAP2/miR-1-3p/CENPF axis to affect ferroptosis of colorectal cancer cells
目的 探究放疗调控的circRNA ACAP2(ACAP2)异常表达对结直肠癌细胞铁死亡的影响.方法 实时荧光定量PCR(qRT-PCR)检测ACAP2在结直肠细胞NCM460和结直肠癌细胞HCT116、DLD-1、SW620和SW480中的表达.SW620细胞和 SW480 细胞分为 Control 组、4Gy+NC 组、4Gy+ACAP2 OE 组和 4Gy+ACAP2 OE+si-CENPF 组,CCK-8、流式细胞术以及Transwell法检测细胞增殖、凋亡、迁移和侵袭能力;流式细胞术和Mito-tracker Red染色检测各组细胞活性氧(ROS)表达和线粒体损伤;试剂盒检测各组细胞半胱氨酸(Cys)、谷胱甘肽过氧化物酶4(GPX4)、铁(Iron)和丙二醛(MDA)浓度;Western blot检测各组细胞GPX4、铁蛋白重链1(FTH1)和溶质载体家族7成员11(SLC7A11)蛋白表达;双荧光素酶报告验证ACAP2和miR-1-3p的靶向关系,以及miR-1-3p和着丝粒蛋白F(CENPF)靶向关系.结果 ACAP2在HCT116、DLD-1、SW620和SW480细胞中的表达高于其在NCM460细胞中的表达(P<0.05).与Control组比较,4Gy+NC组SW620细胞和SW480细胞增殖、迁移、侵袭能力显著降低(P<0.05),GPX4、FTH1和SLC7A11蛋白表达显著下调(P<0.05),Cys和GPX4浓度显著降低(P<0.001),细胞凋亡、线粒体损伤、细胞Iron和MDA浓度显著增加(P<0.05);与4Gy+NC组相比,4Gy+ACAP2 OE组SW620细胞和SW480细胞增殖、迁移、侵袭能力显著增加(P<0.01),GPX4、FTH1和SLC7A11蛋白表达显著上调(P<0.05),Cys和GPX4浓度显著增加(P<0.05),细胞凋亡、线粒体损伤、细胞Iron和MDA浓度显著降低(P<0.05).双荧光素酶报告基因结果显示miR-1-3p为ACAP2靶基因,CENPF为miR-1-3p的靶基因.4Gy+ACAP2 OE+si-CENPF 组SW620细胞和SW480细胞GPX4、FTH1和SLC7A11表达水平均显著低于4Gy+ACAP2 OE组(P<0.05),Cys和GPX4浓度显著低于4Gy+ACAP2 OE组(P<0.05),细胞Iron和MDA浓度显著高于4Gy+ACAP2 OE组(P<0.05).结论 放疗可下调ACAP2表达抑制miR-1-3p/CENPF信号轴而诱导结直肠癌细胞铁死亡.
Objective To investigate the effect of abnormal expression of circRNA ACAP2(ACAP2)regulated by radiotherapy on ferroptosis of colorectal cancer.Methods RT-qPCR was used to detect the expression of ACAP2 in normal human colon mucosal epithelial NCM460 cells,and colorectal cancer cell HCT116,DLD-1,SW620,and SW480 cells.SW620 cells and SW480 cells were divided into Control group,4Gy+NC group,and 4Gy+ACAP2 OE group,The CCK-8,Flow cytometry,and Transwell assays were used to detect the prolifera-tion,apoptosis,migration,and invasion ability.Flow cytometry and Mito-tracker Red staining were used to de-tect Reactive Oxygen Species(ROS)and mitochondrial damage.The reagent kits were used to detect the con-centrations of Cysteine(Cys),Glutathione peroxidase 4(GPX4),Iron,and Malondialdehyde(MDA).West-ern blot was used to detect the protein expression of GXP1,FTH1,and SLC7A11.The dual luciferase reporter assay validated the targeting relationship between ACAP2,miR-1-3p,and CENPF.Results The expression of ACAP2 was higher in HCT116,DLD-1,SW620,and SW480 cells than in NCM460 cells(P<0.05).Com-pared with the Control group,the proliferation,migration,invasion of SW620 cells and SW480 cells in the 4Gy+NC group were significantly reduced(P<0.05),and the protein expression of GXP1,FTH1,and SLC7A11 were significantly downregulated(P<0.05),the concentrations of Cys and GPX4 were significantly reduced(P<0.05),and cell apoptosis,mitochondrial damage,Iron and MDA concentration were significantly in-creased(P<0.05).Compared with the 4Gy+NC group,the proliferation,migration,invasion of SW620 cells and SW480 cells in the 4Gy+ACAP2 OE group were significantly increased(P<0.05),the expression of GXP1,FTH1,and SLC7A11 proteins was significantly upregulated(P<0.05),the concentrations of Cys and GPX4 were significantly increased(P<0.05),and the cell apoptosis,mitochondrial damage,Iron and MDA concentration were significantly reduced(P<0.05).The dual luciferase reporter assay showed that miR-1-3p is the target gene of ACAP2,and CENPF is the target gene of miR-1-3p.The expression levels of GPX4,FTH1,and SLC7A11 in SW620 and SW480 cells in the 4Gy+ACAP2 OE+si-CENPF group were significantly lower than those in the 4Gy+ACAP2 OE group(P<0.05).the concentrations of Cys and GPX4 were significantly lower than those in the 4Gy+ACAP2 OE group(P<0.05),and the Iron and MDA concentration were signifi-cantly higher than those in the 4Gy+ACAP2 OE group(P<0.05).Conclusion Radiotherapy can downregulate ACAP2 expression to inhibit miR-1-3p/CENPF signaling axis and induce ferroptosis of colorectal cancer cells.
朱成斌;茅芯慧;古力米拉木·艾热提
新疆维吾尔自治区人民医院放疗中心,新疆乌鲁木齐 830001新疆维吾尔自治区人民医院放疗中心,新疆乌鲁木齐 830001新疆维吾尔自治区人民医院放疗中心,新疆乌鲁木齐 830001
医药卫生
ACAP2miR-1-3pCENPF结直肠癌铁死亡
ACAP2miR-1-3pCENPFcolorectal cancerferroptosis
《遵义医科大学学报》 2026 (1)
58-68,11
新疆维吾尔自治区自然科学基金资助项目(NO:2022D01C642).
评论